Publications

Seo S, Healey BE, McLin R, Sacks NC, Benson CJ, Citrome L. 2024. Impact of demographics and insurance coverage on schizophrenia treatment and healthcare resource utilization within an integrated healthcare system. Neuropsychiatr Dis Treat 20(Sept 26):1837–1848; doi: 10.2147/NDT.S473492. PMID: 39351585.

DiBiase JF, Scharnetzki E, Edelman E, Reed EK, Helbig P, Rueter J, Miesfeldt S, Frankenfeld CL, et al. 2024. Socioeconomic and urban-rural disparities in genome-matched treatment receipt and survival after genomic tumor testing. JNCI Cancer Spectr 8(5):pkae090; doi: 10.1093/jncics/pkae090. PMID: 39312685.

Wilson KP, Valazza E, Price C. 2024. Video modeling to support social communication goals of autistic adults: A tutorial. Am J Speech Lang Pathol 33(5):2249–2265; doi: 10.1044/2024_AJSLP-23-00479. PMID: 39028571.

Perry CS, Verwiel AH, Covington TR, Proctor DM. 2024. PBPK modeling demonstrates that exposure time adjustment is unnecessary for setting an acute manganese inhalation exposure guideline. Regul Toxicol Pharmacol 153(Nov):105698; doi: 10.1016/j.yrtph.2024.105698. PMID: 39251127.

Patlewicz G, Judson RS, Williams AJ, Butler T, Barone Jr. S, Carstens K, Cowden J, Dawson JD, et al. 2024. Development of chemical categories for per- and polyfluoroalkyl substances (PFAS) and the proof-of-concept approach to the identification of potential candidates for tiered toxicological testing and human health assessment. Comput Toxicol 131(Sep 1):100327; doi: 10.1016/j.comtox.2024.100327. PMID: 40547594.

Wingrat J, Price C, Wright T. 2024. Facilitators of and barriers to caregiver adherence to home therapy recommendations for infants and children with neuromotor and neuromuscular diagnoses: A scoping review. Am J Occup Ther 78(5):7805205070; doi: 10.5014/ajot.2024.050567. PMID: 39083636.

Gawehn E, Greene N, Miljković F, Obrezanova O, Subramanian V, Trapotsi M, Winiwarter S. 2024. Perspectives on the use of machine learning for ADME prediction at AstraZeneca. Xenobiotica 54(7):368-378; doi: 10.1080/00498254.2024.2352598. PMID: 39166404.

Barker TH, McBride GM, Dias M, Price C, Munn Z. 2024. Contextual factors and G6PD diagnostic testing: A scoping review and evidence and gap map. Malaria J 23(1):241; doi: 10.1186/s12936-024-05050-6. PMID: 39135005.

Reynolds JI, Choi J, Johnson BP. 2024. Crowdsourcing AOP development: Leveraging the thesis literature review to identify knowledge gaps and facilitate research translation. Curr Res Toxicol 7(Aug 8):100191; doi: 10.1016/j.crtox.2024.100191. PMID: 39205829.

Jackson JW, Frederick C Streich Jr, Pal A, Coricor G, Boston C, …, Wood M, et al. 2024. An antibody that inhibits TGF-β1 release from latent extracellular matrix complexes attenuates the progression of renal fibrosis. Sci Signal 17(844):eadn6052; doi: 10.1126/scisignal.adn6052. PMID: 38980922.

Pollock D, Bailey HD, Hasanoff S, Munn Z, Valenzuela C, Stern C, Price C, et al. 2024. First Nations Peoples’ perceptions, knowledge and beliefs regarding stillbirth prevention and bereavement practices: A mixed methods systematic review. Women Birth 37(4):101604; doi: 10.1016/j.wombi.2024.101604. PMID: 38640744.

Bean K, Jones SA, Chakrapani A, Vijay S, Wu T, Church H, … Jensen I, et al. 2024. Exploring the cost-effectiveness of newborn screening for metachromatic leukodystrophy (MLD) in the UK. Int J Neonatal Screen 10(3):45; doi: 10.3390/ijns10030045. PMID: 39051401.

Rudisill C, Jacobs M, Roy M, Brown L, Eaton R, Malloy T, Davies H, Tickner JT. 2024. The use of alternatives assessment in chemicals management policies: Needs for greater impact. Integr Environ Assess Manag 20(4):1035-1045; doi: 10.1002/ieam.4826. PMID: 37658263.

Thompson CM, Dewhurst N, Moundous D, Borghoff SJ, Haws LC, Vasquez MZ. 2024. Assessment of the genotoxicity of tert-butyl alcohol in an in vivo thyroid comet assay. Environ Mol Mutagen 65(3–4):129–136; doi: 10.1002/em.22601. PMID: 38717101.

Lin HC, Sakolish C, Moyer HL, Carmichael PL, Baltazar MT, Ferguson SS, Stanko JP, Hewitt P, et al. 2024. An in vitro-in silico workflow for predicting renal clearance of PFAS. Toxicol Appl Pharmacol 489(Aug):117015; doi: 10.1016/j.taap.2024.117015. PMID: 38917890.

Mathisen GH, Bearth A, Jones LB, Hoffmann S, Vist GE, Ames HM,… Wikoff D, Wright F, Whaley P. 2024. Editorial: Time for CHANGE: System-level interventions for bringing forward the date of effective use of NAMs in regulatory toxicology. Arch Toxicol 98(8):2299-2308; doi: 10.1007/s00204-024-03802-6. PMID: 38877155.

Chew DS, Sacks NC, Emden MR, Cyr PL, Sherwood R, Pokorney SD. 2024. Catheter ablation for supraventricular tachycardia and health resource utilization and expenditures: A propensity-matched cohort study. Int J Cardiol 403(May 15):131831; doi: 10.1016/j.ijcard.2024.131831. PMID: 38331201.

Bonkowsky J, Healey B, Sacks NC, McLin R, Cyr PL, Sawyer EK, Stephen CD, et al. 2024. Burden of illness and mortality in men with adrenomyeloneuropathy: A retrospective cohort study. Orph J Rare Dis 19(1):270; doi: 10.1186/s13023-024-0326-w. PMID: 39020416.

Van Herwerden D, Kant E, Jackson M, Fender CL, Garcia-Jaramillo M, O’Brien J, Thomas K, Samanipour S. 2024. Modular open-access and open-source Julia language toolbox for processing of HRMS data: jHRMSToolbox. ChemRxiv; doi: 10.26434/chemrxiv-2024-b713v. Under revision in Environ Sci Technol.

Kenyon MO, Martin M, Martin EA, Brandstetter S, Wegesser T, Greene N, Harvey J. 2024. Deriving acceptable limits for non-mutagenic impurities in medicinal products–Durational adjustments. Regul Toxicol Pharmacol 150(June):105644; doi: 10.1016/j.yrtph.2024.105644. PMID: 38761968.